The HEMA Debate: The Value Judgements Involved in Deciding How “Value” Is Measured: A Value in Health Forum

EntityRisk Co-Founder and Chief Scientific Officer of EntityRisk and Chief Scientific Officer of the USC Schaeffer Center Darius Lakdawalla, PhD, will participate in this ISPOR Europe 2026 forum examining the value judgements embedded in how health economists measure “value.” The session will explore competing methodological frameworks in health economic and outcomes research, the assumptions built into cost-effectiveness analysis, and how different analytic choices can lead to different conclusions about the value of medical technologies.

Upcoming: Let's meet in Vienna?

Join EntityRisk and industry leaders for a discussion on how HEOR and Market Access professionals are navigating the evolving policy, access, and value landscapes.

About EntityRisk

EntityRisk integrates globally renowned health economics and policy expertise with PROVEN™, our advanced modelling software, to predict health outcomes, identify maximum value-based pricing, and substantiate evidence-generation investments.

10 of the Top 20 Biopharma Companies work with EntityRisk to navigate the shifting policy landscape and confidently choose and defend justifiable prices, inform evidence investments, and communicate and win on value.

10 / 20

Top Biopharma Companies

1,300+

Quality Checks

5

ML Modules